Wonkyung Jung
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Artificial Intelligence-Powered Human Epidermal Growth Factor Receptor 2 Quantification and Clinical Outcomes in Human Epidermal Growth Factor Receptor 2-Positive Biliary Tract Cancer Treated With Trastuzumab Plus Folinic Acid, Fluorouracil, and Oxaliplatin.
Journal: JCO precision oncology
Published: October 02, 2025
Artificial intelligence-detected HER2 strong-positive tumor proportion predicts FISH positivity and treatment response in breast cancer.
Journal: PloS one
Published: June 17, 2025
Agreement Across 10 Artificial Intelligence Models in Assessing Human Epidermal Growth Factor Receptor 2 (HER2) Expression in Breast Cancer Whole-Slide Images.
Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: May 28, 2025
Agreement Across 10 Artificial Intelligence Models in Assessing HER2 Expression in Breast Cancer Whole Slide Images.
Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: May 28, 2025
OCELOT 2023: Cell detection from cell-tissue interaction challenge.
Journal: Medical image analysis
Published: October 21, 2024
A universal immunohistochemistry analyzer for generalizing AI-driven assessment of immunohistochemistry across immunostains and cancer types.
Journal: NPJ precision oncology
Published: June 27, 2024
Prognostic Significance of the Immune Microenvironment in Endometrial Cancer.
Journal: Laboratory investigation; a journal of technical methods and pathology
Published: June 04, 2024
Clinical Validation of Artificial Intelligence-Powered PD-L1 Tumor Proportion Score Interpretation for Immune Checkpoint Inhibitor Response Prediction in Non-Small Cell Lung Cancer.
Journal: JCO precision oncology
Published: May 09, 2024
Inflamed immune phenotype predicts favorable clinical outcomes of immune checkpoint inhibitor therapy across multiple cancer types.
Journal: Journal for immunotherapy of cancer
Published: January 27, 2024
An artificial intelligence-powered PD-L1 combined positive score (CPS) analyser in urothelial carcinoma alleviating interobserver and intersite variability.
Journal: Histopathology
Published: December 08, 2023
Augmented interpretation of HER2, ER, and PR in breast cancer by artificial intelligence analyzer: enhancing interobserver agreement through a reader study of 201 cases.
Journal: Breast cancer research : BCR
Published: December 06, 2023
Deep learning model improves tumor-infiltrating lymphocyte evaluation and therapeutic response prediction in breast cancer.
Journal: NPJ breast cancer
Published: December 09, 2022
Last Updated: 09/26/2026